Phosphate Binder Tablet Franchise in Ahmedabad

Name: Latobate 700 Tablet (Lanthanum Carbonate 700mg)
Brand: Latobate 700 Tablet
Rating: 4.8 (150 reviews)

Lanthanum Carbonate Tablet Supplier in Mumbai

Renal Care Tablet Distributor in Delhi

Nephrology Tablet Manufacturer in Bangalore

CKD Management Tablet Stockist in Hyderabad

Lanthanum Carbonate Tablet Exporter in Chandigarh

Home/Products /lanthanum-carbonate-700mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Lanthanum Carbonate 700mg Renal Care Tablet – PCD Pharma Franchise Marketing Material

lanthanum carbonate tablet product video

phosphate binder renal therapy tablet literature PDF

Latobate 700 Tablet

Composition : Lanthanum Carbonate (700mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Lanthanum Carbonate 700mg tablet is a phosphate binder formulation used for managing hyperphosphatemia in patients with chronic kidney disease (CKD), especially those undergoing dialysis.

It works by binding dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream and helping maintain controlled phosphate levels.

This tablet is widely prescribed in chronic kidney disease management, dialysis patient care, and hyperphosphatemia treatment, helping reduce complications associated with elevated phosphate levels.

With increasing demand in nephrology care, strong clinical acceptance among physicians, and essential role in CKD management protocols, this formulation strengthens renal therapy portfolios and supports consistent therapeutic utilization.

About the Product

Lanthanum Carbonate 700mg tablet is a phosphate binder formulation used for managing hyperphosphatemia in patients with chronic kidney disease (CKD), especially those undergoing dialysis.

It works by binding dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream and helping maintain controlled phosphate levels.

Some patients may experience nausea, vomiting, abdominal discomfort, constipation, or diarrhea. These side effects are generally mild and temporary. In rare cases, allergic reactions or severe gastrointestinal symptoms may occur and require medical attention.

Latobate 700 Tablet is indicated for the treatment of hyperphosphatemia in patients with chronic kidney disease, particularly those undergoing dialysis. It helps reduce excessive phosphate levels in the blood, thereby lowering the risk of bone disorders and cardiovascular complications related to kidney disease.

This medicine should be taken under the supervision of a healthcare professional. It is usually administered with meals to ensure effective phosphate binding. Patients with kidney disease should follow dietary phosphate restrictions and regular monitoring as advised by their doctor.

Store in a cool and dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.